Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4857-06-1

Post Buying Request

4857-06-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4857-06-1 Usage

Chemical Properties

BEIGE TO BROWN CRYSTALLINE POWDER

Uses

2-Chlorobenzimidazole is mainly used for the synthesis of medicine and as an intermediate in organic synthesis.

Application

2-Chlorobenzimidazole can be used to synthesize the following: 1-methyl-2-chlorobenzimidazole via reaction with dimethyl sulfate1-ethyl-2-chlorobenzimidazole via reaction with diethyl sulfate1-benzyl-2-chlorobenzimidazole via reaction with benzyl chloride2-chloro-4,5,6,7-tetrabromobenzimidazole via bromination with bromineIt may be used as a building block to synthesize 4-amino-6-benzimidazole-pyrimidines.

General Description

2-Chlorobenzimidazole can be synthesized by reacting benzimidazole-2-one with phosphoryl chloride in the presence of phenol.

Check Digit Verification of cas no

The CAS Registry Mumber 4857-06-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,8,5 and 7 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4857-06:
(6*4)+(5*8)+(4*5)+(3*7)+(2*0)+(1*6)=111
111 % 10 = 1
So 4857-06-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2/c8-7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H,9,10)

4857-06-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A12193)  2-Chlorobenzimidazole, 97%   

  • 4857-06-1

  • 5g

  • 711.0CNY

  • Detail
  • Alfa Aesar

  • (A12193)  2-Chlorobenzimidazole, 97%   

  • 4857-06-1

  • 25g

  • 2252.0CNY

  • Detail
  • Alfa Aesar

  • (A12193)  2-Chlorobenzimidazole, 97%   

  • 4857-06-1

  • 100g

  • 8128.0CNY

  • Detail
  • Aldrich

  • (592277)  2-Chlorobenzimidazole  98%

  • 4857-06-1

  • 592277-5G

  • 544.05CNY

  • Detail
  • Aldrich

  • (592277)  2-Chlorobenzimidazole  98%

  • 4857-06-1

  • 592277-25G

  • 1,630.98CNY

  • Detail

4857-06-1Relevant articles and documents

Design, Synthesis, Cytotoxicity, and Molecular Docking Studies of New Benzimidazole Hybrids as Possible Anticancer Agents

Mishra, Shashank Shekher,Sharma, C. S.

, p. 21 - 29 (2021/08/12)

In the course of efforts to develop new anticancer agents, benzimidazole-based morpholine, thiomorpholine, and piperazine hybrid compounds were designed and synthesized. The structures of the synthesized compounds were confirmed by Proton nuclear magnetic resonance, Carbon-13 NMR, and mass spectroscopy. The title compounds were screened for cytotoxicity against breast and lung cancer cell lines. Compound 6c was found most active against lung cancer cell line with IC50 value of 2.11 μM and compound 10c was found most active against breast cancer cell line with IC50 of 2.23 μM. The molecular docking analysis was also carried out to explore binding pattern of compound with the target protein. All synthesized compounds showed excellent binding affinity toward target protein. Therefore, these findings will be helpful in future drug design of more potent anticancer agents.

Substituted benzimidazoles as modulators of Ras signaling

-

, (2019/12/25)

Benzimidazole compounds that increase the rate of SOS-mediated nucleotide exchange on Ras by binding to a functionally relevant, chemically tractable pocket on the SOS protein, as part of the Ras:SOS:Ras complex.

From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African Trypanosomiasis

Devine, William G.,Diaz-Gonzalez, Rosario,Ceballos-Perez, Gloria,Rojas, Domingo,Satoh, Takashi,Tear, Westley,Ranade, Ranae M.,Barros-álvarez, Ximena,Hol, Wim G. J.,Buckner, Frederick S.,Navarro, Miguel,Pollastri, Michael P.

, p. 225 - 236 (2017/04/21)

Human African trypanosomiasis is a neglected tropical disease that is lethal if left untreated. Existing therapeutics have limited efficacy and severe associated toxicities. 2-(2-(((3-((1H-Benzo[d]imidazol-2-yl)amino)propyl)amino)methyl)-4,6-dichloro-1H-indol-1-yl)ethan-1-ol (NEU-1053) has recently been identified from a high-throughput screen of >42,000 compounds as a highly potent and fast-acting trypanocidal agent capable of curing a bloodstream infection of Trypanosoma brucei in mice. We have designed a library of analogues to probe the structure-activity relationship and improve the predicted central nervous system (CNS) exposure of NEU-1053. We report the activity of these inhibitors of T. brucei, the efficacy of NEU-1053 in a murine CNS model of infection, and identification of the target of NEU-1053 via X-ray crystallography.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4857-06-1